European Multi-Centre Post-Market Registry on Thoracic Endovascular Arch Repair Using Castor™ and Cratos™

The Castor™ and Cratos™ Branched Aortic Stent Graft Systems are medical devices designed for the minimally invasive endovascular treatment of thoracic aortic pathologies in the descending aorta. The goal of this multi-centre retrospective and prospective observational registry study is to capture the short-, medium- to long-term safety and performance data of how Castor™ and Cratos™ stent-grafts work in real-world settings (everyday medical practice). The aim is to study approximately 100 patients in European hospitals, with competitive enrollment.

NCT Number	NCT07668687
Lead Sponsor	Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd
Conditions	Dissection of Thoracic Aorta, Dissection of Thoracic Descending Aorta, Aneurysm of Aorta, Thoracic, Penetrating Aortic Ulcers (PAUs), Intramural Hematoma of the Thoracic Aorta, Ulcer-like Projection (ULP)
Enrollment	100 participants
Start Date	2025-09-12
Primary Completion	2028-10 (estimated)
Study Completion	2033-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-25